Home

subnavHH

 

Specialties

Pancreas Cancer

The Johns Hopkins Medical Institutions is now the leading center in the world for the treatment and study of pancreatic cancer. More than 15 faculty at Johns Hopkins have dedicated their careers to the war on pancreatic cancer. These faculty members include basic science researchers, researchers focused on translating basic science discoveries to patient care, and clinicians (surgeons, oncologists, pathologists, gastroenterologists and radiation oncologists).

For many pancreatic cancer patients, an operation called the Whipple--officially a pancreaticoduodenectomy--remains their only chance of defeating the disease.  But the procedure is risky and few surgeons will attempt it.  Johns Hopkins surgeon John Cameron, M.D., has dedicated his 30-year career to the operation, perfecting it and making it safer.  Today, the mortality rate for the Whipple procedure at Johns Hopkins has dropped to less than 2 percent, a statistic that only a handful of other high-volume hospitals in the United States can claim. 

Surgeons Charles Yeo and Frederick Eckhauser are other Hopkins surgeons who are leading research into identifying the different types of pancreatic cancer early, with the aim of targeting therapies to prevent and treat them.  Through their efforts, Johns Hopkins has become a center of excellence for pancreatic and related cancers.
 



More on Surgery for Pancreas Cancer


Johns Hopkins Centers of Excellence



Back to Specialties List

 

 
Back to top
2006 | All Rights Reserved | Johns Hopkins University and Health System
601 North Caroline Street, Baltimore, Maryland 21287-0765 USA
Contact Us | Johns Hopkins Medicine